51907-18-7 Usage
Uses
Used in Organic Chemistry Research:
5,6-Dihydro-[2]pyrindin-7-one is used as a research compound for exploring its chemical properties and potential reactions within the field of organic chemistry. Its unique structure and the presence of a heterocyclic ring make it an interesting subject for study, which could lead to the discovery of new chemical pathways or reactions.
Used in Pharmaceutical Development:
5,6-Dihydro-[2]pyrindin-7-one is used as a potential pharmaceutical candidate due to its structural characteristics. 5,6-Dihydro-[2]pyrindin-7-one's potential relevance in pharmaceuticals suggests that it could be a key component in the development of new drugs, particularly if its interactions with biological systems can be harnessed effectively. However, further research is required to determine its safety, efficacy, and potential therapeutic applications.
Used in Toxicology Studies:
5,6-Dihydro-[2]pyrindin-7-one is used as a subject in toxicology studies to assess its potential toxicity and environmental impact. Understanding the compound's effects on living organisms and the environment is crucial for determining safe handling procedures and potential regulatory requirements.
Used in Safety Protocol Development:
5,6-Dihydro-[2]pyrindin-7-one is used in the development of safety protocols for researchers and handlers. Given the current lack of information on its toxicity and environmental effects, establishing safe practices for working with 5,6-Dihydro-[2]pyrindin-7-one is essential to protect those who may come into contact with it during research or other applications.
Check Digit Verification of cas no
The CAS Registry Mumber 51907-18-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,9,0 and 7 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 51907-18:
(7*5)+(6*1)+(5*9)+(4*0)+(3*7)+(2*1)+(1*8)=117
117 % 10 = 7
So 51907-18-7 is a valid CAS Registry Number.
51907-18-7Relevant academic research and scientific papers
Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist
Hoashi, Yasutaka,Takai, Takafumi,Kosugi, Yohei,Nakashima, Masato,Nakayama, Masaharu,Hirai, Keisuke,Uchikawa, Osamu,Koike, Tatsuki
, p. 3059 - 3074 (2021/04/06)
To develop potent and orally bioavailable melatonin receptor (MT1 and MT2) agonists, a novel series of 5-6-5 tricyclic derivatives was designed, synthesized, and evaluated. The synthesized indeno[5,4-d][1,3]oxazole, cyclopenta[c]pyrazolo[1,5-a]pyridine, i
DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS
-
Paragraph 0282, (2018/03/28)
Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.
TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF
-
Page/Page column 54-55, (2009/09/26)
The present invention provides a compound represented by the formula wherein R1 is a hydrocarbon group optionally having substituent(s), amino optionally having substituent(s), hydroxy optionally having a substituent or a heterocyclic group opt
